benefit

As the US presidential election approaches in November, analysts expect stock market volatility to rise due to policy uncertainty. The investment bank advises against making material changes to strategic portfolio allocations based solely…

Radical changes to the UK's social care system implemented by the Conservatives over the past decade have disproportionately benefited pensioners and people on disability benefits, while working-age families face significant…

On Wednesday, Citi reiterated a Buy rating on shares of Equinix (NASDAQ:), with a price target of $1,020.00. The company's positive position is based on Equinix's ability to benefit from the ongoing digital transformation of the…

TORONTO, April 23, 2024 (GLOBE NEWSWIRE) -- Equifax (NYSE:) ® Canada, a global data, analytics, and technology company, is committed to helping people live their financial best and to take steps to further financial inclusion for people in…

Paper Boat Creative Companies developing artificial intelligence products and support appear poised to benefit as a wide range of manufacturers begin to incorporate AI into their daily operations. A joint study by Microsoft…

In a move to enhance its multiplatform liquidity bridge, Tools for Brokers (TFB) has partnered with trading solutions provider Devexperts to integrate the DXtrade platform into its Trade Processor ecosystem. Dedicated Forex cloud…

As the Ethereum ecosystem braces for the much-anticipated Dencun upgrade, renowned crypto analyst Miles Deutscher provides an in-depth look at the altcoins poised for significant growth. Scheduled for March 13,…

After a holiday season spent indulging and imbibing many social drinkers welcome the tradition of Dry or Damp January, where you abstain from or cut back on alcohol for a full month as a way of resetting your relationship with it in the new…

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire…

Bristol Myers Squibb (BMS) has the broadest ongoing cell therapy development program in CD19-positive malignancies with Breyanzi, which also includes trials investigating its use in patients with relapsed/refractory mantle cell lymphoma…